MarketInOut Stock Screener Log In | Sign Up
 

ANI Pharmaceuticals Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 06/18/2026
ANI Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,807.17 mln
Float19.41 mln
Earnings Date08/12/2026

EPS

3.91
Solid

P / E

20.33
Premium valuation

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.81
Likely reliable

1-Year Forecast

113
Exceptional upside

Relative Strength

63 / 100
Outperforming

Business Description

ANI Pharmaceuticals is a U.S.-based drug maker that produces and sells a wide range of prescription medicines, including specialty branded treatments and lower-cost generic alternatives. Its product lineup spans injections, capsules, gels, creams, and liquids, with several offerings targeting niche medical conditions. The company supplies healthcare distributors, pharmacies, hospitals, and purchasing groups across the country and in select international markets. Founded in 2001 and based in Baudette, Minnesota, ANI has grown into a diversified player in the pharmaceutical industry.

Key Fundamentals

EPS3.91
P/E20.33
ROE18.33
RPS43.37
ROIC8.64
ROA6.67
Interest Cover5.77
EBITDA, mln224
EV / EBITDA9.59
EV / EBIT15.97
Revenue, mln924
EV / Revenue2.32

Financial Strength

Altman Z-Score2.69
Piotroski F-Score 7 / 9
Beneish M-Score-2.81
Price to Intrinsic Value1.74
Price to Graham Number5.86
1-Year Target Price113
Short Ratio8.34
Short % of Float17.84

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.65% 21 / 100   
1 Month -1.03% 29 / 100   
2 Months 9.66% 65 / 100   
6 Months -1.99% 36 / 100   
1 Year 25.48% 68 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us